Syncom Formulations India Ltd — Quarterly Results & Earnings

₹10.30

-5.36%

Profit Growth YoY53.79%Latest quarter

Sales Growth YoY19.66%Latest quarter

Sales CAGR 5Y17.51%5 year compound

Profit CAGR 5Y27.71%5 year compound

📋

Quarterly Performance

YoY Profit Growth+53.79%

🔥 Exceptional growth

YoY Sales Growth+19.66%

✅ Strong growth

OPM 5Y Average

Operating profit margin

11.41%

EPS Growth 5Y

23.05%

Interest Coverage

Higher = safer debt servicing

105.39

ROE

15.50%

ROCE

18.59%

💡

Growth Analysis

Syncom Formulations India Ltd reported YoY profit growth of 53.79% and revenue growth of 19.66% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 17.51% and profits at 27.71% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Syncom Formulations India Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.